{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:25:52Z","timestamp":1785223552401,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbadis.2025.167729","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:45:05Z","timestamp":1739897105000},"page":"167729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["VRK2 promotes colorectal cancer growth and impedes immunotherapy and 5-FU treatment efficacy"],"prefix":"10.1016","volume":"1871","author":[{"given":"Yu-Tong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Lei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Xiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167729_bb0005","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2025.167729_bb0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3322\/caac.21728","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2025.167729_bb0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2025.167729_bb0020","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS WT-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials","volume":"28","author":"Arnold","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","article-title":"Targeted therapy for head and neck cancer: signaling pathways and clinical studies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167729_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167729_bb0035","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2016.58","article-title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","volume":"13","author":"Boutros","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ccell.2024.03.001","article-title":"Clinical drug screening reveals clofazimine potentiates the efficacy whilereducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy","volume":"42","author":"Xue","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167729_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.19.01586","article-title":"PD-1 blockade in advanced adrenocortical carcinoma","volume":"38","author":"Raj","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","article-title":"Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2025.167729_bb0070","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1074\/jbc.M310813200","article-title":"Characterization of three paralogous members of the mammalian vaccinia related kinase family","volume":"279","author":"Nichols","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167729_bb0075","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1742-4658.2006.05256.x","article-title":"The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines","volume":"273","author":"Blanco","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2025.167729_bb0080","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41423-021-00673-0","article-title":"VRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release","volume":"18","author":"He","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001660","article-title":"Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein","volume":"3","author":"Blanco","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.167729_bb0090","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41388-021-01893-4","article-title":"Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation","volume":"40","author":"Zhu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2025.167729_bb0095","doi-asserted-by":"crossref","first-page":"42739","DOI":"10.1074\/jbc.M112.404285","article-title":"Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2","volume":"287","author":"V\u00e1zquez-Cedeira","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2025.167729_bb0100","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.7150\/ijbs.66313","article-title":"VRK2 activates TNF\u03b1\/NF-\u03baB signaling by phosphorylating IKK\u03b2 in pancreatic cancer","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2025.167729_bb0105","first-page":"749","article-title":"Emerging biological functions of the vaccinia-related kinase (VRK) family","volume":"24","author":"Klerkx","year":"2009","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0110","first-page":"3933","article-title":"Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1\/2\/AKT signal pathway by targeting miR-145-5p","volume":"25","author":"Mu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2025.167729_bb0115","doi-asserted-by":"crossref","first-page":"20528","DOI":"10.1073\/pnas.1905973116","article-title":"The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells","volume":"116","author":"Yin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbadis.2025.167729_bb0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.32604\/or.2023.031031","article-title":"Vaccinia-related kinase 2 variants differentially affect breast cancer growth by regulating kinase activity","volume":"32","author":"Gwak","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbadis.2025.167729_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12885-016-2574-9","article-title":"Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study","volume":"16","author":"Del Puerto-Nevado","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2025.167729_bb0130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167729_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2957-3_1","article-title":"Cell cycle control: a system of interlinking oscillators","volume":"1342","author":"Poon","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.167729_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-017-9726-5","article-title":"Mutations of key driver genes in colorectal cancer progression and metastasis","volume":"37","author":"Huang","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2025.167729_bb0145","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","article-title":"Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer","volume":"11","author":"Kwon","year":"2021","journal-title":"Cancer Discov."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:59:32Z","timestamp":1741298372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0925443925000742"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167729","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VRK2 promotes colorectal cancer growth and impedes immunotherapy and 5-FU treatment efficacy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167729"}}